These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 27011346)

  • 1. Core-matched encapsulation of an oleate prodrug into nanostructured lipid carriers with high drug loading capability to facilitate the oral delivery of docetaxel.
    Sun B; Luo C; Li L; Wang M; Du Y; Di D; Zhang D; Ren G; Pan X; Fu Q; Sun J; He Z
    Colloids Surf B Biointerfaces; 2016 Jul; 143():47-55. PubMed ID: 27011346
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Formulating a single thioether-bridged oleate prodrug into a self-nanoemulsifying drug delivery system to facilitate oral absorption of docetaxel.
    Cui W; Zhang S; Zhao H; Luo C; Sun B; Li Z; Sun M; Ye Q; Sun J; He Z
    Biomater Sci; 2019 Feb; 7(3):1117-1131. PubMed ID: 30638237
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cysteine-Functionalized Nanostructured Lipid Carriers for Oral Delivery of Docetaxel: A Permeability and Pharmacokinetic Study.
    Fang G; Tang B; Chao Y; Xu H; Gou J; Zhang Y; Xu H; Tang X
    Mol Pharm; 2015 Jul; 12(7):2384-95. PubMed ID: 25974386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RIPL peptide-conjugated nanostructured lipid carriers for enhanced intracellular drug delivery to hepsin-expressing cancer cells.
    Lee SG; Kim CH; Sung SW; Lee ES; Goh MS; Yoon HY; Kang MJ; Lee S; Choi YW
    Int J Nanomedicine; 2018; 13():3263-3278. PubMed ID: 29910614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Size-exclusive effect of nanostructured lipid carriers on oral drug delivery.
    Li H; Chen M; Su Z; Sun M; Ping Q
    Int J Pharm; 2016 Sep; 511(1):524-537. PubMed ID: 27452421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanostructured lipid carriers as novel carrier for parenteral delivery of docetaxel.
    Liu D; Liu Z; Wang L; Zhang C; Zhang N
    Colloids Surf B Biointerfaces; 2011 Jul; 85(2):262-9. PubMed ID: 21435845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics and tissue distribution of docetaxel by liquid chromatography-mass spectrometry: evaluation of folate receptor-targeting amphiphilic copolymer modified nanostructured lipid carrier.
    Zhao X; Zhao Y; Geng L; Li X; Wang X; Liu Z; Wang D; Bi K; Chen X
    J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Dec; 879(31):3721-7. PubMed ID: 22035980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Repaglinide-loaded nanostructured lipid carriers with different particle sizes for improving oral absorption: preparation, characterization, pharmacokinetics, and
    Wu L; Zhao L; Su X; Zhang P; Ling G
    Drug Deliv; 2020 Dec; 27(1):400-409. PubMed ID: 31729898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic efficacy of lipid emulsions of docetaxel-linoleic acid conjugate in breast cancer.
    Zhang T; Li M; Yang R; Zhang D; Guan J; Yu J; Yang B; Zhang H; Zhang S; Liu D; Wang Y
    Int J Pharm; 2018 Jul; 546(1-2):61-69. PubMed ID: 29763687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preparation and characteristics of nanostructured lipid carriers for control-releasing progesterone by melt-emulsification.
    Yuan H; Wang LL; Du YZ; You J; Hu FQ; Zeng S
    Colloids Surf B Biointerfaces; 2007 Nov; 60(2):174-9. PubMed ID: 17656075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploring the Promising Potential of High Permeation Vesicle-Mediated Localized Transdermal Delivery of Docetaxel in Breast Cancer To Overcome the Limitations of Systemic Chemotherapy.
    Bathara M; Date T; Chaudhari D; Ghadi R; Kuche K; Jain S
    Mol Pharm; 2020 Jul; 17(7):2473-2486. PubMed ID: 32496783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved Bioavailability and Antitumor Effect of Docetaxel by TPGS Modified Proniosomes: In Vitro and In Vivo Evaluations.
    Liu H; Tu L; Zhou Y; Dang Z; Wang L; Du J; Feng J; Hu K
    Sci Rep; 2017 Mar; 7():43372. PubMed ID: 28266539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design and characterization of Amoitone B-loaded nanostructured lipid carriers for controlled drug release.
    Luan J; Zhang D; Hao L; Li C; Qi L; Guo H; Liu X; Zhang Q
    Drug Deliv; 2013 Nov; 20(8):324-30. PubMed ID: 24032657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Docetaxel-nicotinamide complex-loaded nanostructured lipid carriers for transdermal delivery.
    Fan X; Chen J; Shen Q
    Int J Pharm; 2013 Dec; 458(2):296-304. PubMed ID: 24177313
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glioblastoma multiforme targeted delivery of docetaxel using bevacizumab-modified nanostructured lipid carriers impair in vitro cell growth and in vivo tumor progression.
    Di Filippo LD; Lobato Duarte J; Hofstätter Azambuja J; Isler Mancuso R; Tavares Luiz M; Hugo Sousa Araújo V; Delbone Figueiredo I; Barretto-de-Souza L; Miguel Sábio R; Sasso-Cerri E; Martins Baviera A; Crestani CC; Teresinha Ollala Saad S; Chorilli M
    Int J Pharm; 2022 Apr; 618():121682. PubMed ID: 35307470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics and Biodistribution of Thymoquinone-loaded Nanostructured Lipid Carrier After Oral and Intravenous Administration into Rats.
    Zakarial Ansar FH; Latifah SY; Wan Kamal WHB; Khong KC; Ng Y; Foong JN; Gopalsamy B; Ng WK; How CW; Ong YS; Abdullah R; Aziz MY
    Int J Nanomedicine; 2020; 15():7703-7717. PubMed ID: 33116496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparation and evaluation of PEGylated asiatic acid nanostructured lipid carriers on anti-fibrosis effects.
    Chen X; Zhang Y; Zhao P; Chen Y; Zhou Y; Wang S; Yin L
    Drug Dev Ind Pharm; 2020 Jan; 46(1):57-69. PubMed ID: 31813288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanostructured lipid carriers used for oral delivery of oridonin: an effect of ligand modification on absorption.
    Zhou X; Zhang X; Ye Y; Zhang T; Wang H; Ma Z; Wu B
    Int J Pharm; 2015 Feb; 479(2):391-8. PubMed ID: 25556104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Docetaxel-loaded ultrasmall nanostructured lipid carriers for cancer therapy: in vitro and in vivo evaluation.
    Li M; Pei J; Ma Z; Fu J; Chen F; Du S
    Cancer Chemother Pharmacol; 2020 Apr; 85(4):731-739. PubMed ID: 32146495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chlorogenic acid stabilized nanostructured lipid carriers (NLC) of atorvastatin: formulation, design and in vivo evaluation.
    Khan S; Baboota S; Ali J; Narang RS; Narang JK
    Drug Dev Ind Pharm; 2016; 42(2):209-20. PubMed ID: 26016780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.